Differential expression of PD-L1 and PD-L2 is associated with the tumor microenvironment of TILs and M2 TAMs and tumor differentiation in non-small cell lung cancer

To improve the treatment strategy of immune-checkpoint inhibitors for non-small cell lung cancer (NSCLC), a comprehensive analysis of programmed death-ligand (PD-L)1 and PD-L2 expression is clinically important. The expression of PD-L1 and PD-L2 on both tumor cells (TCs) and tumor-infiltrating immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Sumitomo, Ryota, Huang, Cheng-Long, Fujita, Masaaki, Cho, Hiroyuki, Date, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867258/
https://www.ncbi.nlm.nih.gov/pubmed/35169863
http://dx.doi.org/10.3892/or.2022.8284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867258/
https://www.ncbi.nlm.nih.gov/pubmed/35169863
http://dx.doi.org/10.3892/or.2022.8284

Ejemplares similares